Small Molecules

23 Feb 2007 Hollis-Eden Pharmaceuticals Presents Additional Positive Data with Novel Steroid Hormone in Models of Prostate and Breast Cancer
23 Feb 2007 Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
23 Feb 2007 Auris Medical initiating phase I/II clinical trial with AM-101
22 Feb 2007 Pharmacyclics Receives Refuse to File Letter for Xcytrin
22 Feb 2007 Manhattan Pharmaceuticals, Inc. Completes Enrollment In Phase 2a Study Of Oral Oleoyl-estrone For Obesity
22 Feb 2007 Sosei Announces Progression of SD118 Towards Phase 1 Studies
22 Feb 2007 Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva(R) in Treating Atopic Dermatitis
22 Feb 2007 Landark study shows important benefits of Seretide(TM) mtreatment for patients with fatal lung disease, COPD
21 Feb 2007 BioMarin Announces Results From Phase 2 Clinical Study of 6R-BH4 in Poorly Controlled Hypertension
21 Feb 2007 Lux Biosciences Initiates LUMINATE Pivotal Clinical Trials of Its Next-Generation Calcineurin Inhibitor, LX211, in Uveitis
21 Feb 2007 Roche and GSK agree on two transactions
21 Feb 2007 Avalon Pharmaceuticals Announces the Initiation of Drug Discovery Program for the MYC Oncoprotein - One of the Most Important and Intractable Cancer Targets
21 Feb 2007 Alteon's Investigational Drug Alagebrium Demonstrates Ability to Improve Functional Membrane Transport in a Rat Model of Chronic Peritoneal Dialysis, Indicating a Potential Role in Kidney Disease
21 Feb 2007 Novacea's ASCENT Phase 2 Trial Published in the Journal of Clinical Oncology
21 Feb 2007 Theravance Announces FDA Acceptance of Telavancin NDA
21 Feb 2007 Hana Biosciences Reports Likely Delay in Launch of Zensana
20 Feb 2007 Basilea Reports Positive Phase III Results for Alitretinoin
20 Feb 2007 CeNeS Pharmaceuticals plc: Successful Phase III results announced on Lead Product M6G
20 Feb 2007 Cardiome and Astellas Announce Acceptance of NDA for Review
17 Feb 2007 GPC Biotech Submits NDA for Lead Oncology Drug Candidate Satraplatin
17 Feb 2007 Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorization in the European Union
17 Feb 2007 Positive outcome from pre-Phase III FDA and EMEA scientific advice meetings for VitorTM
17 Feb 2007 Roche files application in Europe for Tamiflu 30 and 45 mg capsules
17 Feb 2007 InSite Vision Announces License Agreement With Inspire Pharmaceuticals
17 Feb 2007 Gilead's New Drug Application for Ambrisentan Receives Priority Review Status

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up